Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cipla
Queensland Health
Federal Trade Commission
Express Scripts
Citi
Johnson and Johnson
Colorcon
Mallinckrodt

Generated: February 16, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for NAMENDA XR

« Back to Dashboard

Payment Methods and Pharmacy Types for NAMENDA XR (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $130,072,634
INSIDE ANOTHER STORE $301,032,954
[disabled in preview] $430,698,573
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 248,782
INSIDE ANOTHER STORE 649,802
[disabled in preview] 1,017,257
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICARE $634,276,096
OTHER INSURANCE $5,359,330
[disabled in preview] $223,868,572
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for NAMENDA XR
Drug Units Sold Trends for NAMENDA XR

Annual Sales Revenues and Units Sold for NAMENDA XR

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
NAMENDA XR ➤ Try a Free Trial ➤ Try a Free Trial 2016
NAMENDA XR ➤ Try a Free Trial ➤ Try a Free Trial 2015
NAMENDA XR ➤ Try a Free Trial ➤ Try a Free Trial 2014
NAMENDA XR ➤ Try a Free Trial ➤ Try a Free Trial 2013
NAMENDA XR ➤ Try a Free Trial ➤ Try a Free Trial 2012
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
AstraZeneca
Cerilliant
Chinese Patent Office
Harvard Business School
Cantor Fitzgerald
US Army
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.